BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21547354)

  • 1. Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity.
    Yasue A; Hasegawa K; Udagawa Y
    Hum Cell; 2011 Jun; 24(2):65-73. PubMed ID: 21547354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic characterization of tamoxifen-associated endometrial cancer.
    Prasad M; Wang H; Douglas W; Barakat RR; Ellenson LH
    Gynecol Oncol; 2005 Jan; 96(1):25-31. PubMed ID: 15589576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases.
    Nagy E; Gajjar KB; Patel II; Taylor S; Martin-Hirsch PL; Stringfellow HF; Martin FL; Phillips DH
    Br J Cancer; 2014 Jun; 110(12):2874-80. PubMed ID: 24853176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.
    Miturski R; Bogusiewicz M; Tarkowski R; Ciotta C; Bignami M; Burnouf D; Jakowicki JA
    Oncol Rep; 2003; 10(4):1039-43. PubMed ID: 12792767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability at a tetranucleotide repeat in type I endometrial carcinoma.
    Choi YD; Choi J; Kim JH; Lee JS; Lee JH; Choi C; Choi HS; Lee MC; Park CS; Juhng SW; Nam JH
    J Exp Clin Cancer Res; 2008 Dec; 27(1):88. PubMed ID: 19116039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen.
    Turbiner J; Moreno-Bueno G; Dahiya S; Sánchez-Estevez C; Hardisson D; Prat J; Oliva E; Palacios J
    Mod Pathol; 2008 Aug; 21(8):925-36. PubMed ID: 18500270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability.
    Hardisson D; Moreno-Bueno G; Sánchez L; Sarrió D; Suárez A; Calero F; Palacios J
    Mod Pathol; 2003 Nov; 16(11):1148-58. PubMed ID: 14614055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
    Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
    Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of hMLH1 expression is associated with less aggressive clinicopathological features in sporadic endometrioid endometrial adenocarcinoma.
    Ju W; Park HM; Lee SN; Sung SH; Kim SC
    J Obstet Gynaecol Res; 2006 Oct; 32(5):454-60. PubMed ID: 16984511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression.
    Feng YZ; Shiozawa T; Miyamoto T; Kashima H; Kurai M; Suzuki A; Konishi I
    Clin Cancer Res; 2005 Sep; 11(17):6133-8. PubMed ID: 16144912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the K-ras and p53 genes in Tamoxifen-associated endometrial carcinoma.
    Fujiwara K; Enomoto T; Fujita M; Kanda T; Fujii S; Ito K; Wakasa K; Ishiko O; Ueda M; Yamaguchi S; Kimura T; Umesaki N
    Oncol Rep; 2008 May; 19(5):1293-8. PubMed ID: 18425390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.
    Nout RA; Bosse T; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; van Eijk R; Ter Haar NT; Smit VT
    Gynecol Oncol; 2012 Sep; 126(3):466-73. PubMed ID: 22609107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma.
    Baldinu P; Cossu A; Manca A; Satta MP; Pisano M; Casula M; Dessole S; Pintus A; Tanda F; Palmieri G
    Cancer; 2002 Jun; 94(12):3157-68. PubMed ID: 12115348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.
    Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB
    Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series.
    Macdonald ND; Salvesen HB; Ryan A; Malatos S; Stefansson I; Iversen OE; Akslen LA; Das S; Jacobs IJ
    Int J Gynecol Cancer; 2004; 14(5):957-65. PubMed ID: 15361209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of Endometrial Carcinoma.
    Lax SF
    Adv Exp Med Biol; 2017; 943():75-96. PubMed ID: 27910065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma.
    Peiró G; Diebold J; Lohse P; Ruebsamen H; Lohse P; Baretton GB; Löhrs U
    Hum Pathol; 2002 Mar; 33(3):347-54. PubMed ID: 11979377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences.
    Chiaravalli AM; Furlan D; Facco C; Tibiletti MG; Dionigi A; Casati B; Albarello L; Riva C; Capella C
    Virchows Arch; 2001 Jan; 438(1):39-48. PubMed ID: 11213834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Expression and Clinical Significance of DNA Methyltransferase 3B (DNMT3B), Phosphatase and Tensin Homolog (PTEN) and Human MutL Homologs 1 (hMLH1) in Endometrial Carcinomas.
    Li W; Wang Y; Fang X; Zhou M; Li Y; Dong Y; Wang R
    Med Sci Monit; 2017 Feb; 23():938-947. PubMed ID: 28220037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
    Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F
    Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.